car-t in multiple myeloma: cilta-cel & ide-cel
Published 2 years ago • 289 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
5:56
advances in car-t therapy for r/r multiple myeloma: ide-cel & cilta-cel
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
3:03
the future of car-t therapy for multiple myeloma
-
2:17
cilta-cel: a paradigm shift in the treatment of multiple myeloma
-
0:48
selecting patients with multiple myeloma for car-t therapy
-
4:04
the future of myeloma treatment and the possibility of cure
-
6:18
what to expect with car t cell therapy and bispecifics in myeloma (2022) | dr. joshua richter
-
5:55
car t-cell therapy for multiple myeloma
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
8:29
car-t therapy options for multiple myeloma
-
1:33
ide-cel car t-cell therapy in newly diagnosed high-risk myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
9:48
the use of car t-cells in multiple myeloma
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
3:24
approved and emerging car-ts in multiple myeloma
-
1:15
ide-cel car t-cell therapy for r/r myeloma in karmma-3
-
1:45
car t-cells in myeloma: patients’ perspective
-
2:22
treating multiple myeloma with cilta-cel in earlier settings
-
3:27
car-t cells in myeloma
-
2:09
cartitude-1: cilta-cel improves hrqol for patients with myeloma